Advancements in Transplantology Using Genetically Modified Pig Organs

A biotech company, Revivacor, is working on using cloned, genetically modified pigs to provide organs for human transplants, aiming to solve the pressing organ shortage crisis. These pigs have ten identical genetic modifications designed to create organs that are compatible with human patients, reducing the risk of rejection and complications like blood clots. During a recent surgery, the first pig kidney from this project was transplanted into a patient, showcasing a novel approach that could change the landscape of transplant medicine. The operation is especially noteworthy as it addresses the urgent need, given that more than 100,000 people in the U.S. are on transplant waiting lists, with many dying without receiving a suitable organ.